Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Bradley K Ackerson"'
Autor:
Katia J Bruxvoort, Lina S Sy, Jeff Slezak, Bradley K Ackerson, Lei Qian, Sijia Qiu, Zendi Solano, Kristi Reynolds
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
HepB-CpG is a licensed adjuvanted two-dose hepatitis B vaccine for adults, with limited data on exposure during pregnancy. We assessed the risk of pregnancy outcomes among individuals who received HepB-CpG or the 3-dose HepB-alum vaccine ≤28 d prio
Externí odkaz:
https://doaj.org/article/48919e4ad46246bcae76f575b44a1a4c
Autor:
Deborah E Malden, Sara Y Tartof, Bradley K Ackerson, Vennis Hong, Jacek Skarbinski, Vincent Yau, Lei Qian, Heidi Fischer, Sally F Shaw, Susan Caparosa, Fagen Xie
Publikováno v:
JMIR Public Health and Surveillance, Vol 8, Iss 12, p e41529 (2022)
BackgroundNatural language processing (NLP) of unstructured text from electronic medical records (EMR) can improve the characterization of COVID-19 signs and symptoms, but large-scale studies demonstrating the real-world application and validation of
Externí odkaz:
https://doaj.org/article/624f73ba47a9409681536ec2d6c428fa
Autor:
Sara Y Tartof, Lei Qian, Liyan Liu, Devin Incerti, Jacek Skarbinski, Laura B Amsden, Bradley K Ackerson, Vennis Hong, Bruce H Fireman, Vincent M Yau, Heidi Fischer, Sally F Shaw
Publikováno v:
BMJ Open, Vol 12, Iss 10 (2022)
Objectives Assess the association between tocilizumab administration and clinical outcomes among mechanically ventilated patients with COVID-19 pneumonia.Design Retrospective cohort study.Setting Large integrated health system with 9 million members
Externí odkaz:
https://doaj.org/article/bbfd3cd482434b3584ba78b0efecad85
Autor:
Ana Florea, Lina S Sy, Yi Luo, Lei Qian, Katia J Bruxvoort, Bradley K Ackerson, Gina S Lee, Jennifer H Ku, Julia E Tubert, Yun Tian, Carla A Talarico, Hung Fu Tseng
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0267824 (2022)
BackgroundWe conducted a prospective cohort study at Kaiser Permanente Southern California to study the vaccine effectiveness (VE) of mRNA-1273 over time and during the emergence of the Delta variant.MethodsThe cohort for this planned interim analysi
Externí odkaz:
https://doaj.org/article/c446828e016646d9abbf9e3dd70dfc7b
Autor:
Katia J. Bruxvoort, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Gina S. Lee, Yun Tian, Ana Florea, Harpreet S. Takhar, Julia E. Tubert, Carla A. Talarico, Hung Fu Tseng
Publikováno v:
The Lancet Regional Health. Americas, Vol 6, Iss , Pp 100134- (2022)
Summary: Background: Phase 3 trials found mRNA-1273 was highly effective in preventing COVID-19. We conducted a prospective cohort study at Kaiser Permanente Southern California (KPSC) to determine the real-world vaccine effectiveness (VE) of mRNA-12
Externí odkaz:
https://doaj.org/article/2480a17f26064f04903b9f83ca4b3743
Autor:
Sara Y, Tartof, Jeff M, Slezak, Laura, Puzniak, Vennis, Hong, Timothy B, Frankland, Fagen, Xie, Bradley K, Ackerson, Srinivas R, Valluri, Luis, Jodar, John M, McLaughlin
Publikováno v:
The Lancet Respiratory Medicine. 11:176-187
The SARS-CoV-2 omicron (B.1.1.529 BA.1) lineage was first detected in November, 2021, and is associated with reduced vaccine effectiveness. By March, 2022, BA.1 had been replaced by sub-lineage BA.2 in the USA. As new variants evolve, vaccine perform
Autor:
Deborah E. Malden, Julianne Gee, Sungching Glenn, Zhuoxin Li, Cheryl Mercado, Oluwaseye A. Ogun, Sunhea Kim, Bruno J. Lewin, Bradley K. Ackerson, Amelia Jazwa, Eric S. Weintraub, Michael M. McNeil, Sara Y. Tartof
Publikováno v:
Vaccine. 41:315-322
Studies combining data from digital surveys and electronic health records (EHR) can be used to conduct comprehensive assessments on COVID-19 vaccine safety.We conducted an observational study using data from a digital survey and EHR of children aged
Autor:
Ana Florea, Lina S Sy, Lei Qian, Bradley K Ackerson, Yi Luo, Julia E Tubert, Gina S Lee, Jennifer H Ku, Katia J Bruxvoort, Carla A Talarico, Sijia Qiu, Yun Tian, Hung Fu Tseng
Publikováno v:
Clinical Infectious Diseases. 76:252-262
Background We conducted a prospective cohort study at Kaiser Permanente Southern California to evaluate the relative vaccine effectiveness (rVE) of a booster dose vs 2-dose primary series of messenger RNA (mRNA)-1273 in immunocompetent individuals. M
Autor:
Joseph A Lewnard, John M McLaughlin, Debbie Malden, Vennis Hong, Laura Puzniak, Bradley K Ackerson, Bruno J Lewin, Jeniffer S Kim, Sally F Shaw, Harpreet Takhar, Luis Jodar, Sara Y Tartof
Publikováno v:
The Lancet. Infectious diseases, vol 23, iss 7
BackgroundIn the USA, oral nirmatrelvir-ritonavir is authorised for use in patients aged 12 years or older with mild-to-moderate COVID-19 who are at risk of progression to severe disease and hospitalisation. We aimed to establish the effectiveness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c44cf3e9facb6c38b86da6b65a9c186
https://escholarship.org/uc/item/1cp1x02k
https://escholarship.org/uc/item/1cp1x02k
Autor:
Sara Y Tartof, Timothy B Frankland, Laura Puzniak, Jeff M Slezak, Vennis Hong, Harpreet Takhar, Oluwaseye A Ogun, Sarah Simmons, Fagen Xie, Joann Zamparo, Bradley K Ackerson, Luis Jodar, John M McLaughlin
Publikováno v:
Journal of the Pediatric Infectious Diseases Society. 12:177-179
In a 1:1 matched test-negative design among 5- to 11-year-olds in the Kaiser Permanente Southern California health system (n = 3984), BNT162b2 effectiveness against the omicron-related emergency department or urgent care encounters was 60% [95%CI: 47